Welcome to the TJU BMT Program's World Wide Web Homepage. Our more extended site
is currently down for reconstruction.
For those patients, family, or friends who may be trying to reach us with questions about the services we offer, this page provides a brief statement of our program goals and philosophy and some phone numbers and e-mail addresses, which may help you reach us.
Our program offers an array of autologous and allogeneic transplant options for patients with leukemia, lymphoma, aplastic anemia, breast cancer, ovarian cancer, multiple myeloma, kidney cancer, and other malignancies for which transplantation is commonly employed as therapy. We have also endeavored to help patients with rarer malignancies or medical conditions for which transplantation has been less widely utilized, but is, nonetheless, medically appropriate.
Areas of special interest within the program include:
making transplant possible for individuals who lack well matched donors but are otherwise appropriate allogeneic BMT candidates. We have programs in haploidentical transplantation for such patients.
reducing the risks inherent in allogeneic BMT using newer "minitransplant" approaches when appropriate.
reducing the incidence and severity of GVHD in unrelated donor BMT using a newly available CD4 lymphocyte inhibitor developed in the Kimmel Cancer Center of Thomas Jefferson University.
using allogeneic transplantation (specifically minitransplants and donor lymphocyte infusions) to treat immunosensitive malignancies such as melanoma and renal cell carcinoma.
newer applications of stem cell transplantation including autoimmune diseases and sickle cell anemia.
If you would like to reach us to discuss these options, you can contact Janet Brunner, PA-C, our Senior Coordinator, for information or an appointment at (215) 955-0352. Our main program number is (215) 955-4367. If you would like, you can also reach us by e-mail at Janet.Brunner@mail.tju.edu, if this is more convenient.
We apologize for the inconvenience of this temporary web page.
Neal Flomenberg, MD
Program Director
Patient care materials for TJU personnel may be reached through this link on a password protected basis.
Kimmel Cancer Center - Clinical Trials Search
**Not
getting prompted for Secure Website, click here**